Furthermore, Kaplan–Meier analysis using the log-rank test was conducted and the result showed that patients with low STOML2 expression had a longer median survival time of 68 months than those with high STOML2 expression, whose median survival time was 45 months (P = 0.004; Fig. 1g) indicating a worse prognosis outcome for CRC patients with high STOML2 expression. The gene discussed is STOML2; the disease is colorectal carcinoma.